We have developed a comprehensive reading list of original scientific research papers from the past decade relating to psilocybin-assisted psychotherapy in the treatment of end-of-life distress.
This bibliography is appended to our application to Health Canada and forms the basis of our scientific argument that psilocybin-assisted psychotherapy is a clinically appropriate treatment for the patients we describe.
Of particular significance are the four articles highlighted in green. The first two (found in Section A) report the latest and most robust clinical trials; the second two (found in Section B) are comprehensive reviews of the research history and summaries of results. We encourage you to begin with these. You can access the full text of these articles by clicking on them.
The items in this bibliography collectively document that more than 2000 doses of psilocybin have been safely administered since the early ‘90s.
They affirm a consistency and coherence of results across research papers, and the high degree of agreement among research teams, across institutions, and across continents. They also show a notable lack of peer-reviewed criticism of the basic findings.
Collectively, they indicate that psilocybin-assisted psychotherapy is an effective and low-risk treatment for end-of-life distress of cancer patients when conducted according to research-established protocols by suitably trained therapists.